United States v. Al-Bataineh

CourtCourt of Appeals for the Tenth Circuit
DecidedDecember 21, 2000
Docket00-3125
StatusUnpublished

This text of United States v. Al-Bataineh (United States v. Al-Bataineh) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Al-Bataineh, (10th Cir. 2000).

Opinion

F I L E D United States Court of Appeals Tenth Circuit UNITED STATES COURT OF APPEALS DEC 21 2000 TENTH CIRCUIT PATRICK FISHER Clerk

UNITED STATES OF AMERICA,

Plaintiff-Appellee, No. 00-3125 v. (District of Kansas) (D.C. No. 99-CR-40002-02-SAC) RAED MOHAMMAD AL- BATAINEH,

Defendant-Appellant.

ORDER AND JUDGMENT *

Before BRORBY, KELLY, and MURPHY, Circuit Judges.

After examining the briefs and appellate record, this panel has determined

unanimously that oral argument would not materially assist the determination of

this appeal. See Fed. R. App. P. 34(a)(2); 10th Cir. R. 34.1(G). The court

therefore honors the parties’ requests and orders the case submitted without oral

argument.

* This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3. After Raed Mohammad Al-Bataineh pleaded guilty to possession of

pseudoephedrine in violation of 21 U.S.C. § 841(d)(2), the district court

sentenced him to a term of imprisonment of twenty-eight months. On appeal, Al-

Bataineh asserts that the district court erred in refusing to reduce his offense level

pursuant to United States Sentencing Guidelines § 2D1.11(b)(2). This court

exercises jurisdiction pursuant to 28 U.S.C. § 1291 and 18 U.S.C. § 3742(a)(2)

and affirms.

Al-Bataineh was stopped by state law enforcement officials while driving

on Interstate-70 through Shawnee County, Kansas. Al-Bataineh agreed to a

request by the officers to search the vehicle. Inside the trunk, officers found an

exceedingly large number of bottles containing pseudoephedrine tablets; each

bottle had been opened and repackaged so that it contained at least twice, and

possibly as many as five times, the number of tablets indicated on the label. In

total, officers found 321,275 tablets of pseudoephedrine in the vehicle, weighing

approximately 19.3 kilograms.

Al-Bataineh was arrested following the stop and agreed to submit to an

interview with an agent of the Drug Enforcement Agency. During the interview,

Al-Bataineh admitted that he was “hauling” the pseudoephedrine from Ohio to

Nevada and that he was to be paid $1200 for doing so. Apparently, Al-Bataineh

had sold his business less than two months prior to the acts constituting the

-2- instant offense. He utilized part of the profits from that sale to finance the

purchase of the pseudoephedrine.

After local Kansas authorities declined to file charges, Al-Bataineh was

released from custody. Approximately two weeks later, Al-Bataineh was again

arrested for committing a similar offense in Oklahoma City, Oklahoma.

Al-Bataineh was eventually charged in United States District Court for the

District of Kansas with possessing “approximately 19 kilograms of

pseudoephedrine, a list I chemical, having reasonable cause to believe that the

listed chemical will be used to manufacture a controlled substance.” Al-Bataineh

eventually entered into a plea agreement with the government wherein he agreed

to plead guilty to the information and waive grand jury indictment. In return, the

government agreed to file no further charges for the actions at issue in the

information, to recommend a three-level downward adjustment for acceptance of

responsibility, and to file a motion for downward departure pursuant to U.S.S.G. §

5K1.1 to reflect Al-Bataineh’s substantial assistance to the government.

At the time of his plea, Al-Bataineh submitted the following statement

detailing his involvement in the offense:

On December 18, 1998, I was driving through the state of Kansas with Mohammed Ahmad-Abu-Hardan. We were in a car which had within it a lot of repackaged cold medicine (Minithins, mainly).

While I do not have a lot of knowledge about how drugs are manufactured, based on the fact that the seals on the bottles had been

-3- broken, and five bottles worth of pills had been transferred to one bottle, there was reasonable cause for me to believe that the drugs in my car would eventually be used to help manufacture a controlled substance.

I knew that the Minithins were in my car, and I knew we were taking them to California to sell them for a profit. I am very sorry to have violated the drug laws of the United States.

After the district court accepted Al-Bataineh’s guilty plea, the United States

Probation Office prepared a presentence investigation report (“PSR”). The PSR

concluded that Al-Bataineh had an offense level of 25 and a criminal history

category of I, resulting in a sentencing range of 57 to 71 months. The PSR

arrived at Al-Bataineh’s offense level by reference to the chemical quantity table

set out in U.S.S.G. § 2D1.11(d). Because Al-Bataineh possessed between six and

twenty kilograms of pseudoephedrine, he started with an offense level of 28. See

U.S.S.G. § 2D1.11(d)(2). The PSR recommended that Al-Bataineh receive a

three-level reduction in his offense level pursuant to U.S.S.G. § 3E1.1(a) and (b),

resulting in an ultimate offense level of 25.

Al-Bataineh objected to the PSR, asserting that his offense level should be

decreased by three additional levels pursuant to U.S.S.G. § 2D1.11(b)(2). That

section of the Guidelines provides as follows: “If the defendant is convicted of

violating . . . § 841(d)(2) . . . , decrease by 3 levels, unless the defendant knew or

believed that the listed chemical was to be used to manufacture a controlled

-4- substance unlawfully.” 1 In particular, Al-Bataineh asserted that although he

clearly violated § 841(d)(2) because he had reason to believe pseudoephedrine

would be used to manufacture a controlled substance, none of the information in

the PSR demonstrated he was actually aware the pseudoephedrine would be used

to manufacture illegal drugs.

In denying Al-Bataineh’s objection, the district court found as follows:

As the time of his plea, the defendant admitted that the broken seals on the bottles and the packaging of five bottles worth of pills into one bottle gave him reasonable cause to believe the pseudoephedrine would be used to manufacture a controlled substance. The offense conduct set out in the PSR includes more incriminating and culpable circumstances than those admitted by the defendant. The defendant sold his business in October of 1998 and used part of the proceeds to pay for the pseudoephedrine involved in the instant offense. The defendant was operating a vehicle on I-70 in Shawnee County, Kansas, when law enforcement officers stopped him on December 18, 1998. Officers searched the trunk of the vehicle and found 11 cases and four additional boxes of pills called “Mini-Pseudos.” The bottles in those cases had been opened and more pills were added to each bottle. Officers found approximately 321,275 pills of pseudoephedrine. During his post-arrest interview,

1 The purpose behind this provision is elucidated as follows in the commentary to U.S.S.G. § 2D1.11: Convictions under . . . § 841(d)(2) . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Burridge
191 F.3d 1297 (Tenth Circuit, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Al-Bataineh, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-al-bataineh-ca10-2000.